Sycai Medical Startup to Develop Hospital Pilot for ACCION Program

November 18, 2026

AstraZeneca Spain, in collaboration with Wayra and investor Kunsen, have selected the startup Sycai Medical to carry out the ACTION hospital pilot, the accelerator for innovative health initiatives that the three companies launched in November 2025.

Sycai Medical will now explore, together with AstraZeneca Spain and the Hospital de la Santa Creu i Sant Pau in Barcelona, the potential of artificial intelligence applied to the diagnosis of liver tumors.

The startup is developing AI-powered technology to analyze medical images, detect and monitor pancreatic and liver lesions early, and integrate into hospital systems. The project is expected to evaluate new tools that could help improve the detection and diagnosis of these liver tumors.

Laura Colón, President of AstraZeneca Spain, says: “The ACTION initiative embodies the innovation we believe in at AstraZeneca: one that arises from real clinical needs and undergoes rigorous evaluation. Through collaboration with the entrepreneurial ecosystem, we drive tangible solutions with a very clear purpose: to bring innovation to patients while continuing to strengthen access and equity, ensuring that technological and biomedical potential translates into lasting improvements in people’s health.”

“ACTION demonstrates the value of connecting entrepreneurial talent with the real needs of the health system. At Wayra we have contributed our technological and acceleration expertise to support eight startups, and now Sycai Medical has the opportunity to take another step with a hospital pilot. Through initiatives like this, we also contribute to Telefónica’s goal of becoming the best pathway for citizens to access digital technologies,” says Andrés Saborido, CEO of Wayra.

Advertencia, desplácete para continuar leyendo

Selection Criteria

The selection of Sycai Medical for the pilot at the Hospital de la Santa Creu i Sant Pau represents the next step in this first edition, designed to connect the needs of the care sector with technologies developed by the entrepreneurial ecosystem and to facilitate their evaluation in healthcare settings.

“Being selected by ACTION from more than 60 startups is an extraordinary validation of our work. The collaboration with the Hospital de la Santa Creu i Sant Pau allows us to demonstrate in a real clinical environment what our technology can contribute to the early diagnosis of liver tumors. This pilot is a key step in our mission to turn every abdominal CT into an opportunity for early detection,” says Alfonso Martínez, CEO of Sycai Medical.

“ACTION has brought together startups, healthcare professionals, industry, and partners around four challenges. This first edition ends with the Sycai Medical pilot in Sant Pau, an opportunity to demonstrate what artificial intelligence can contribute to early diagnosis,” notes Adrián Gorritxo, Strategy Director at Kunsen.

ACTION, a accelerator of disruptive projects to drive innovation in high-impact therapeutic areas for health, has received in its first edition applications from 60 startups and more than 40 healthcare professionals, who submitted proposals addressing four major areas: oncology; cardiovascular, renal, and metabolic diseases; respiratory and immunological pathologies; and the technological and process challenges facing the health system. Of the 60 startups registered, eight were selected to participate in a six-month acceleration program.

Garrett Mercer

I cover business, startups, and the companies shaping today’s economy. My work focuses on breaking down complex topics into clear, useful insights, with a strong interest in growth strategies and market shifts. I aim to deliver content that is both informative and easy to understand for a wide audience.

Get in Touch with Our Team
Have a question, a partnership opportunity, or a story to share? Reach out to us and connect with a media platform focused on business insights and growth.